Biotech News 20 Mar 2024 New DNA Origami Platform, DoriVac, Opens New Path for Designer Cancer Vaccine Development The central ingredient of therapeutic cancer vaccines is antigens, which are preferentially produced or newly produced (neoantigens) by tumor cells… Pantitra
Biotech News 04 Mar 2024 Innovative New Vaccine Technology Uses DNA Particles That Pretend To Be Viruses Scientists hope the approach could make it easier to create vaccines against trickier viruses like HIV. A new vaccine against… Pantitra
Biotech News 27 Jun 2023 Advancing the development of vaccines through recombinant technology What is the current status of vaccine development? Vaccines come with an inherent societal benefit that goes beyond safeguarding individuals from… Pantitra
BioNet News, Covid-19, Press Releases 21 Mar 2022 Technovalia, Sypharma and BioNet announce the establishment of Genetis, the first Australian Vaccine Development and Manufacturing Hub for mRNA, DNA and recombinant vaccines. Supachai
BioNet News, Covid-19, Press Releases 18 Jan 2022 COVALIA study update: Interim Safety Results from needle-free SARS-CoV2 DNA vaccine phase 1 trial Melbourne 17 January 2022 –Technovalia, an Australian biotech vaccine developer today announced the interim safety results of the ongoing phase… Supachai